30.69BMarket Cap-90.81P/E (TTM)
247.050High237.250Low543.22KVolume245.670Open246.580Pre Close130.98MTurnover0.42%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High947.89P/B30.56BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM3.97%Amplitude3.650Historical Low241.122Avg Price1Lot Size
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet